Pathogenicity assessment of a TSC2 c.2966+1G>A splice site variant in vaginal adenocarcinoma
Kenny, P. A.
Show abstract
Clinical sequencing of a vaginal adenocarcinoma specimen yielded a reported TSC2 variant which was classified as splice-modulating loss-of-function, prompting consideration of a clinical trial for tumors with TSC2 loss. Literature review suggested that germline alterations affecting this particular exon are considered non-pathogenic, raising concern about the initial somatic variant interpretation. To resolve this ambiguity, raw data were provided by Tempus and an integrated DNA & RNA analysis allowed detailed characterization of the impact of this alteration on splicing. We confirm that this variant results in the complete exclusion of exon 26 from the transcript, however the exon 25-27 splice results in an in-frame transcript. Analysis of many additional wild-type tumor and normal tissue samples demonstrate that exon 26 is commonly spliced out of TSC2 transcripts, indicating that the transcript containing the exon 25-27 splice is highly unlikely to be pathogenic. This analysis did not support the classification of this variant as pathogenic and suggests that patients with such mutations should not be candidates for therapeutics designed for TSC2 dysfunction.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genomic profile in TGCT Mexican patients reveals a potential biomarker of sensitivity to platinum-based therapy 93%
- The clinical, genomic, and transcriptomic landscape of BRAF mutant cancers 91%
- DNA mismatch repair gene variant classification: evaluating the utility of somatic mutations and mismatch repair deficient colonic crypts and endometrial glands 91%
Similar papers in this journal
- Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Cancers Identifies KMT2C as a Potential Tumor Suppressor 92%
- Circulating tumor fraction analyses with ultra-low pass whole genome sequencing predict response to chemoradiation and recurrence in stage IV small cell carcinoma of the cervix: a longitudinal case study 91%
- Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent manner 91%
Similar papers in this journal
- Validation of Genomic and Transcriptomic Models of Homologous Recombination Deficiency in a Real-World Pan-Cancer Cohort 90%
- Gene networks and expression quantitative trait loci associated with platinum-based chemotherapy response in high-grade serous ovarian cancer 89%
- NSMCE2, a Novel Super-Enhancer Regulated Gene, is Linked to Poor Prognosis and Therapy Resistance in Breast Cancer 88%
Similar papers in this journal
- Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma 91%
- Interrogating the Precancerous Evolution of Pathway Dysfunction in Lung Squamous Cell Carcinoma Using XTABLE 90%
- Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity 89%
Similar papers in this journal
- Germline testing data validate inferences of mutational status for variants detected from tumor-only sequencing 92%
- Normalized LST is an efficient biomarker for homologous recombination deficiency and Olaparib response in ovarian carcinoma 90%
- Mutational footprint of platinum chemotherapy in a secondary thyroid cancer 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.